All In Biotech

Drug Trial Radar · NCT06701526

A Trial of Eptinezumab in Participants With Migraine and Insufficient Response to Anti-CGRP Medications

Interventional, Open-label Trial, Investigating the Effectiveness of Eptinezumab in Participants With Migraine and Previous Inadequate Response to CGRP-targeting Therapies

Last checked: Nov 20, 2026Latest source record: Sep 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

164

Actual

Start

Dec 18, 2024

Primary completion

Sep 2, 2026

Study completion Sep 2, 2026

Sponsor

Lead sponsor
H. Lundbeck A/SIndustry
Sponsor type
Industry
First posted
Nov 22, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main goal of this trial is to learn whether eptinezumab improves migraine symptoms and quality of life of participants with migraine who did not perceive a sufficient improvement during previous treatment with therapies targeting calcitonin gene-related peptide (CGRP).

Conditions

  • Migraine

Interventions

  • EptinezumabDrug

    Solution for infusion

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants with Response of "Much Improved" or "Very Much Improved" on the Patient Global Impression of Change (PGIC) ScaleTime frame: Week 24

Locations

21 sites in 1 country. Site status is shown where the registry gives one.

  • St. Joseph's Hospital and Medical Center-Barrow Neurological Institute - Barrow Brain Tumor Resea...

    Phoenix, Arizona

  • Mayo Clinic - Vascular Center - Arizona

    Phoenix, Arizona

  • Baptist Health Center for Clinical Research (BHCCR)

    Little Rock, Arkansas

  • The Neuron Clinic - Escondido

    San Marcos, California

  • Sunwise Clinical Research, LLC

    Walnut Creek, California

  • Hasbani Neurology - New Haven

    New Haven, Connecticut

  • New England Institute for Neurology and Headache (NEINH) - Stamford

    Stamford, Connecticut

  • Brainstorm Research, Inc.

    Miami, Florida

  • Chicago Headache Center and Research Institute - Chicago

    Chicago, Illinois

  • Crescent City Headache and Neurology Center

    Chalmette, Louisiana

  • Neurology Center of New England, PC

    Foxborough, Massachusetts

  • Mass Institute of Clinical Research

    Westborough, Massachusetts

  • Michigan Headache & Neurological Institute (MHNI)

    Ann Arbor, Michigan

  • Albany Medical College

    Albany, New York

  • Dent Neurosciences Research Center

    Amherst, New York

  • North Suffolk Neurology - Port Jefferson Station

    Port Jefferson Station, New York

  • Headache Wellness Center

    Greensboro, North Carolina

  • C7 Research

    Cleveland, Ohio

  • Thomas Jefferson University Hospital - Breast Care Center

    Philadelphia, Pennsylvania

  • Preferred Primary Care Physicians - Pleasant Hills - Curry Hollow Road

    Pittsburgh, Pennsylvania

  • KCA Neurology, PLLC

    Franklin, Tennessee

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.